{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T17:36:45Z","timestamp":1794591405494,"version":"4.9.1"},"reference-count":55,"publisher":"BMJ","issue":"5","license":[{"start":{"date-parts":[[2025,5,5]],"date-time":"2025-05-05T00:00:00Z","timestamp":1746403200000},"content-version":"unspecified","delay-in-days":4,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Australian Centre for Accelerating Diabetes Innovations and Breakthrough","award":["2-SRA-2025-1614-M-B"],"award-info":[{"award-number":["2-SRA-2025-1614-M-B"]}]},{"DOI":"10.13039\/100011946","name":"Abbott Diabetes Care","doi-asserted-by":"crossref","award":["Material support"],"award-info":[{"award-number":["Material support"]}],"id":[{"id":"10.13039\/100011946","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2025,4,16]]},"published-print":{"date-parts":[[2025,5]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Sodium-glucose co-transporter inhibitors have potential glycaemic and non-glycaemic benefits in people with type 1 diabetes (T1D). However, the increased risk of diabetic ketoacidosis (DKA) limits their widespread use. We hypothesise that dapagliflozin 10\u2009mg daily, combined with the use of continuous ketone monitoring (CKM) and education strategies to mitigate progression to DKA, will demonstrate improved glycaemic control without increasing DKA events.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and analysis<\/jats:title>\n                    <jats:p>PARTNER is a multisite 6-month randomised crossover double-masked study involving Australian adults with T1D who have a Haemoglobin A1c (HbA1c) &lt;85.8\u2009mmol\/mol (&lt;10%), minimum total daily insulin dose \u22650.4\u2009IU\/kg, consume \u2265100\u2009g carbohydrates\/day and have not had DKA in the last 3\u2009months. All participants will undergo a 2-week run-in period wearing the Abbott FreeStyle Libre 2 Continuous Glucose Monitor (CGM) and Abbott CKM device. Following this, participants are randomised to receive dapagliflozin or placebo for 12\u2009weeks, followed by crossover for a further 12 weeks separated by a 2-week washout period. The primary effectiveness outcome is the Abbott FreeStyle Libre 2 CGM time in range during the final 2\u2009weeks of each stage. The primary safety outcome is the number of episodes of DKA requiring hospitalisation or emergency department presentation. 60 participants will be recruited across five sites.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Ethics and dissemination<\/jats:title>\n                    <jats:p>The study has received ethical approval from the St Vincent\u2019s Hospital Melbourne Human Research Ethics Committee (HREC reference 302\/23). The results will be published in peer-reviewed journals and presented at national and international diabetes conferences.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration number<\/jats:title>\n                    <jats:p>ACTRN12624000448549.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2024-098457","type":"journal-article","created":{"date-parts":[[2025,5,6]],"date-time":"2025-05-06T22:50:25Z","timestamp":1746571825000},"page":"e098457","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":11,"title":["Rationale and design of a randomised phase II multicentre crossover trial investigating a sodium-glucose co-transporter 2 inhibitor, dapagliflozin, combined with a novel continuous ketone monitor in adults with type 1 diabetes to reduce the risk of diabetic ketoacidosis: the PARTNER study"],"prefix":"10.1136","volume":"15","author":[{"given":"Jennifer","family":"Ngan","sequence":"first","affiliation":[{"name":"Department of Endocrinology and Diabetes, St Vincent\u2019s Hospital Melbourne, Fitzroy, Victoria, Australia"},{"name":"Department of Medicine, University of Melbourne, Fitzroy, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7099-8983","authenticated-orcid":false,"given":"Yee Wen","family":"Kong","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Diabetes, St Vincent\u2019s Hospital Melbourne, Fitzroy, Victoria, Australia"},{"name":"Department of Medicine, University of Melbourne, Melbourne, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenna","family":"Goad","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Melbourne, Fitzroy, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael L H","family":"Huang","sequence":"additional","affiliation":[{"name":"Baker Heart and Diabetes Institute, Melbourne, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alicia","family":"Jenkins","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Diabetes, St Vincent\u2019s Hospital Melbourne, Fitzroy, Victoria, Australia"},{"name":"Department of Medicine, University of Melbourne, Fitzroy, Victoria, Australia"},{"name":"Baker Heart and Diabetes Institute, Melbourne, Victoria, Australia"},{"name":"Australian Centre for Accelerating Diabetes Innovations, School of Medicine, University of Melbourne, Parkville, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Vogrin","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Melbourne, Fitzroy, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Trawley","sequence":"additional","affiliation":[{"name":"Department of Medicine, The University of Melbourne, Melbourne, Victoria, Australia"},{"name":"Cairnmillar Institute, Hawthorn, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adele","family":"Manzoney","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Centre for Research in Education in Diabetes and Obesity, Austin Health, Heidelberg, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miyuki","family":"Nakano","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Centre for Research in Education in Diabetes and Obesity, Austin Health, Heidelberg, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elif","family":"Ekinci","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Melbourne, Fitzroy, Victoria, Australia"},{"name":"Australian Centre for Accelerating Diabetes Innovations, School of Medicine, University of Melbourne, Parkville, Victoria, Australia"},{"name":"Department of Endocrinology and Centre for Research in Education in Diabetes and Obesity, Austin Health, Heidelberg, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adamandia","family":"Kriketos","sequence":"additional","affiliation":[{"name":"Department of Diabetes and Endocrinology, The Royal Melbourne Hospital, Parkville, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Spiros","family":"Fourlanos","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Melbourne, Fitzroy, Victoria, Australia"},{"name":"Australian Centre for Accelerating Diabetes Innovations, School of Medicine, University of Melbourne, Parkville, Victoria, Australia"},{"name":"Department of Diabetes and Endocrinology, The Royal Melbourne Hospital, Parkville, Victoria, Australia"},{"name":"Department of Medicine, The Royal Melbourne Hospital, University of Melbourne, Parkville, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynelle","family":"Boisseau","sequence":"additional","affiliation":[{"name":"Department of Diabetes and Endocrinology, Canberra Health Services, Garran, Canberra, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6964-3819","authenticated-orcid":false,"given":"Christopher J","family":"Nolan","sequence":"additional","affiliation":[{"name":"Australian Centre for Accelerating Diabetes Innovations, School of Medicine, University of Melbourne, Parkville, Victoria, Australia"},{"name":"Department of Diabetes and Endocrinology, Canberra Health Services, Garran, Canberra, Australia"},{"name":"School of Medicine and Psychology, Australian National University, Acton, Canberra, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pamela","family":"Taylor","sequence":"additional","affiliation":[{"name":"Southern Adelaide Diabetes and Endocrine Services, Oaklands Park, South Australia, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanne","family":"Fenn","sequence":"additional","affiliation":[{"name":"Southern Adelaide Diabetes and Endocrine Services, Oaklands Park, South Australia, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen N","family":"Stranks","sequence":"additional","affiliation":[{"name":"Southern Adelaide Diabetes and Endocrine Services, Oaklands Park, South Australia, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0870-4032","authenticated-orcid":false,"given":"David Norman","family":"O\u2019Neal","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Diabetes, St Vincent\u2019s Hospital Melbourne, Fitzroy, Victoria, Australia"},{"name":"Department of Medicine, University of Melbourne, Fitzroy, Victoria, Australia"},{"name":"Australian Centre for Accelerating Diabetes Innovations, School of Medicine, University of Melbourne, Parkville, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2025,5,6]]},"reference":[{"key":"2025101813581677000_15.5.e098457.1","doi-asserted-by":"publisher","DOI":"10.1089\/dia.2018.0384"},{"key":"2025101813581677000_15.5.e098457.2","doi-asserted-by":"publisher","DOI":"10.1111\/dme.12676"},{"key":"2025101813581677000_15.5.e098457.3","doi-asserted-by":"publisher","DOI":"10.2337\/dc15-0078"},{"key":"2025101813581677000_15.5.e098457.4","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1007\/s13300-023-01399-0","article-title":"Gaps Remain for Achieving HbA1c Targets for People with Type 1 or Type 2 Diabetes Using Insulin: Results from NHANES 2009-2020","volume":"14","author":"Hankosky","year":"2023","journal-title":"Diabetes Ther"},{"key":"2025101813581677000_15.5.e098457.5","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2014.16107"},{"key":"2025101813581677000_15.5.e098457.6","doi-asserted-by":"publisher","DOI":"10.2337\/dc16-2523"},{"key":"2025101813581677000_15.5.e098457.7","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1016\/S2213-8587(17)30308-X","article-title":"Efficacy and safety of dapagliflozin in patients with inadequately controlled type 1 diabetes (DEPICT-1): 24 week results from a multicentre, double-blind, phase 3, randomised controlled trial","volume":"5","author":"Dandona","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2025101813581677000_15.5.e098457.8","doi-asserted-by":"publisher","DOI":"10.2337\/dc18-1087"},{"key":"2025101813581677000_15.5.e098457.9","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1111\/dom.14060","article-title":"Long-term efficacy and safety of dapagliflozin in patients with inadequately controlled type 1 diabetes (the DEPICT-2 study): 52-week results from a randomized controlled trial","volume":"22","author":"Mathieu","year":"2020","journal-title":"Diabetes Obes Metab"},{"key":"2025101813581677000_15.5.e098457.10","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1812389"},{"key":"2025101813581677000_15.5.e098457.11","doi-asserted-by":"publisher","DOI":"10.1007\/s11892-013-0380-1"},{"key":"2025101813581677000_15.5.e098457.12","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/S2213-8587(20)30280-1","article-title":"Effect of dapagliflozin as an adjunct to insulin over 52 weeks in individuals with type 1 diabetes: post-hoc renal analysis of the DEPICT randomised controlled trials","volume":"8","author":"Groop","year":"2020","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2025101813581677000_15.5.e098457.13","doi-asserted-by":"publisher","DOI":"10.1111\/1753-0407.12890"},{"key":"2025101813581677000_15.5.e098457.14","doi-asserted-by":"publisher","DOI":"10.4158\/EP161292.PS"},{"key":"2025101813581677000_15.5.e098457.15","doi-asserted-by":"crossref","first-page":"3579","DOI":"10.2147\/DMSO.S240903","article-title":"SGLT2 Inhibitors in the Management of Type 1 Diabetes (T1D): An Update on Current Evidence and Recommendations","volume":"16","author":"Maffei","year":"2023","journal-title":"Diabetes Metab Syndr Obes"},{"key":"2025101813581677000_15.5.e098457.16","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1089\/dia.2023.0605","article-title":"Beta-Hydroxybutyrate Levels and Risk of Diabetic Ketoacidosis in Adults with Type 1 Diabetes Treated with Sotagliflozin","volume":"26","author":"Boeder","year":"2024","journal-title":"Diabetes Technol Ther"},{"key":"2025101813581677000_15.5.e098457.17","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1177\/2042018816681706","article-title":"Blood versus urine ketone monitoring in a pediatric cohort of patients with type 1 diabetes: a crossover study","volume":"8","author":"Goffinet","year":"2017","journal-title":"Ther Adv Endocrinol Metab"},{"key":"2025101813581677000_15.5.e098457.18","doi-asserted-by":"crossref","unstructured":"Jenkins AJ , Kilov G , Scott E , et al . n.d. Type 1 Diabetes Glucose Control related Home-Based Testing: A Mini-Review of Tools and Patient Knowledge and Implementation. Madridge J Diabetes 2:55\u201362. doi:10.18689\/mjd-1000111","DOI":"10.18689\/mjd-1000111"},{"key":"2025101813581677000_15.5.e098457.19","doi-asserted-by":"publisher","DOI":"10.1177\/19322968211008185"},{"key":"2025101813581677000_15.5.e098457.20","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1016\/j.dsx.2020.11.002","article-title":"Factors associated with the presence of diabetic ketoacidosis: A retrospective analysis of patients with type 1 diabetes in Saudi Arabia","volume":"14","author":"Al Hayek","year":"2020","journal-title":"Diabetes & Metabolic Syndrome: Clinical Research & Reviews"},{"key":"2025101813581677000_15.5.e098457.21","doi-asserted-by":"publisher","DOI":"10.2337\/dc10-2099"},{"key":"2025101813581677000_15.5.e098457.22","doi-asserted-by":"publisher","DOI":"10.2337\/dc24-S009"},{"key":"2025101813581677000_15.5.e098457.23","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/pedi.13185","article-title":"Previous diabetic ketoacidosis as a risk factor for recurrence in a large prospective contemporary pediatric cohort: Results from the dpv initiative","volume":"22","author":"Hammersen","year":"2021","journal-title":"Pediatr Diabetes"},{"key":"2025101813581677000_15.5.e098457.24","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1210\/clinem\/dgz003","article-title":"The Long-Term Incidence of Hospitalization for Ketoacidosis in Adults with Established T1D\u2014A Prospective Cohort Study","volume":"105","author":"Thomas","year":"2020","journal-title":"The Journal of Clinical Endocrinology & Metabolism"},{"key":"2025101813581677000_15.5.e098457.25","doi-asserted-by":"crossref","DOI":"10.1111\/dme.15178","article-title":"Type 1 diabetes and low carbohydrate diets-Defining the degree of nutritional ketosis","volume":"40","author":"Ozoran","year":"2023","journal-title":"Diabet Med"},{"key":"2025101813581677000_15.5.e098457.26","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1111\/pedi.12496","article-title":"Self-reported regular alcohol consumption in adolescents and emerging adults with type 1 diabetes: A neglected risk factor for diabetic ketoacidosis? Multicenter analysis of 29 630 patients from the DPV registry","volume":"18","author":"Hermann","year":"2017","journal-title":"Pediatr Diabetes"},{"key":"2025101813581677000_15.5.e098457.27","doi-asserted-by":"publisher","DOI":"10.2337\/dc11-0701"},{"key":"2025101813581677000_15.5.e098457.28","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2013.356"},{"key":"2025101813581677000_15.5.e098457.29","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1111\/dom.13124","article-title":"Dapagliflozin in patients with type 2 diabetes mellitus: A pooled analysis of safety data from phase IIb\/III clinical trials","volume":"20","author":"Jabbour","year":"2018","journal-title":"Diabetes Obesity Metabolism"},{"key":"2025101813581677000_15.5.e098457.30","doi-asserted-by":"publisher","DOI":"10.1111\/dom.13811"},{"key":"2025101813581677000_15.5.e098457.31","doi-asserted-by":"publisher","DOI":"10.1089\/dia.2018.0246"},{"key":"2025101813581677000_15.5.e098457.32","doi-asserted-by":"publisher","DOI":"10.1089\/dia.2017.0455"},{"key":"2025101813581677000_15.5.e098457.33","doi-asserted-by":"publisher","DOI":"10.1089\/dia.2010.0156"},{"key":"2025101813581677000_15.5.e098457.34","doi-asserted-by":"publisher","DOI":"10.2337\/dci19-0028"},{"key":"2025101813581677000_15.5.e098457.35","doi-asserted-by":"crossref","first-page":"109000","DOI":"10.1016\/j.diabres.2021.109000","article-title":"Meal-time glycaemia in adults with type 1 diabetes using multiple daily injections vs insulin pump therapy following carbohydrate-counting education and bolus calculator provision","volume":"179","author":"Lu","year":"2021","journal-title":"Diabetes Res Clin Pract"},{"key":"2025101813581677000_15.5.e098457.36","unstructured":"Wenhui Z , Yu L , Baosheng S , et al . Improved HbA1c and reduced glycaemic variability after 1-year intermittent use of flash glucose monitoring. Scientific Reports: Nature Portfolio 2021;1\u20136."},{"key":"2025101813581677000_15.5.e098457.37","doi-asserted-by":"publisher","DOI":"10.2337\/dc24-S006"},{"key":"2025101813581677000_15.5.e098457.38","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1111\/dme.12453","article-title":"Development and validation of the Diabetes Medication System Rating Questionnaire-Short Form","volume":"31","author":"Peyrot","year":"2014","journal-title":"Diabet Med"},{"key":"2025101813581677000_15.5.e098457.39","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.17.7.697"},{"key":"2025101813581677000_15.5.e098457.40","doi-asserted-by":"publisher","DOI":"10.1016\/j.smrv.2015.01.009"},{"key":"2025101813581677000_15.5.e098457.41","doi-asserted-by":"crossref","DOI":"10.1186\/s12955-021-01780-2","article-title":"Validity of EQ-5D-5L health-related quality of life questionnaire in self-reported diabetes: evidence from a general population survey","volume":"19","author":"Jankowska","year":"2021","journal-title":"Health Qual Life Outcomes"},{"key":"2025101813581677000_15.5.e098457.42","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph18179245","article-title":"Health Related Quality of Life Measurements for Diabetes: A Systematic Review","volume":"18","author":"Oluchi","year":"2021","journal-title":"Int J Environ Res Public Health"},{"key":"2025101813581677000_15.5.e098457.43","doi-asserted-by":"publisher","DOI":"10.1159\/000376585"},{"key":"2025101813581677000_15.5.e098457.44","doi-asserted-by":"crossref","DOI":"10.1186\/s12913-017-2031-8","article-title":"Acceptability of healthcare interventions: an overview of reviews and development of a theoretical framework","volume":"17","author":"Sekhon","year":"2017","journal-title":"BMC Health Serv Res"},{"key":"2025101813581677000_15.5.e098457.45","unstructured":"Terry G , Hayfield N , Clarke V , et al . The sage handbook of qualitative research in psychology. SAGE Publications Ltd; 2017. Available: https:\/\/sk.sagepub.com\/reference\/the-sage-handbook-of-qualitative-research-in-psychology"},{"key":"2025101813581677000_15.5.e098457.46","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1177\/1932296818822496","article-title":"The Relationships Between Time in Range, Hyperglycemia Metrics, and HbA1c","volume":"13","author":"Beck","year":"2019","journal-title":"J Diabetes Sci Technol"},{"key":"2025101813581677000_15.5.e098457.47","doi-asserted-by":"publisher","DOI":"10.1089\/dia.2018.0310"},{"key":"2025101813581677000_15.5.e098457.48","doi-asserted-by":"publisher","DOI":"10.2337\/dc18-2316"},{"key":"2025101813581677000_15.5.e098457.49","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph13090837","article-title":"Evaluation of the Accuracy of Capillary Hydroxybutyrate Measurement Compared with Other Measurements in the Diagnosis of Diabetic Ketoacidosis: A Systematic Review","volume":"13","author":"Brooke","year":"2016","journal-title":"Int J Environ Res Public Health"},{"key":"2025101813581677000_15.5.e098457.50","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/dom.15921","article-title":"Continuous ketone monitoring: Exciting implications for clinical practice","volume":"26 Suppl 7","author":"Kong","year":"2024","journal-title":"Diabetes Obes Metab"},{"key":"2025101813581677000_15.5.e098457.51","doi-asserted-by":"publisher","DOI":"10.1007\/s40262-013-0104-3"},{"key":"2025101813581677000_15.5.e098457.52","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1002\/(SICI)1520-7560(199911\/12)15:6<412::AID-DMRR72>3.0.CO;2-8","article-title":"Ketone bodies: a review of physiology, pathophysiology and application of monitoring to diabetes","volume":"15","author":"Laffel","year":"1999","journal-title":"Diabetes Metab Res Rev Nov-Dec"},{"key":"2025101813581677000_15.5.e098457.53","doi-asserted-by":"publisher","DOI":"10.2337\/dc18-1444"},{"key":"2025101813581677000_15.5.e098457.54","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1089\/dia.2023.0141","article-title":"The Association of Time in Range and Diabetic Complications: The Evidence Is Strong","volume":"25","author":"Beck","year":"2023","journal-title":"Diabetes Technol Ther"},{"key":"2025101813581677000_15.5.e098457.55","unstructured":"Alcholism NIoAAa . Drinking levels and patterns defined. Available: https:\/\/www.niaaa.nih.gov\/alcohol-health\/overview-alcohol-consumption\/moderate-binge-drinking#:~:text=Heavy%20Alcohol%20Use%3A&text=For%20men%2C%20consuming%20five%20or,or%20more%20drinks%20per%20week [Accessed 30 Aug 2024]."}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2024-098457","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T20:58:28Z","timestamp":1760821108000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2024-098457"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":55,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2025,5,6]]},"published-print":{"date-parts":[[2025,5]]}},"alternative-id":["10.1136\/bmjopen-2024-098457"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2024-098457","relation":{"has-part":[{"id-type":"doi","id":"https:\/\/doi.org\/10.1136\/bmjopen-2024-098457.supp1","asserted-by":"subject"}]},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5]]}}}